Feed ALPMF
AL

Astellas Pharma Inc. ALPMF · OTC

$17.00 +1.19% (+$0.20)

Summary

75 / 100 · Bulios Score

What speaks for it

  • Out of every 100 JPY of revenue, 16 JPY is left as net profit.
  • The share price is below the Bulios Fair Price.
  • Revenue grew by 14% a year over the last 3 years.
  • It earns 14 JPY a year on every 100 JPY of invested capital.

What to watch

  • Earnings per share fell by 25% a year over the last 3 years.
  • Earnings per share swing sharply from year to year.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Price

Is it expensive?

Looks cheap
Bulios Fair Price
Current price $17
P/E today 12.8
Drug Manufacturers - General industry median

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Today you pay 12.8 JPY for 1 JPY of yearly profit.

Valuation in detail

Is it growing?

It is shrinking

Revenue (JPY)

Diluted EPS (JPY)

  • Analyst estimate

Revenue grew by 8.0% a year over 5 years. Over the last 3 years it grew by 14% a year. For the next fiscal year analysts expect revenue to grow by 12%. Earnings per share fell by 25% a year over the last 3 years.

Growth in detail

Does it make money?

Very well

Where 100 JPY of revenue goes

Net profit, industry median (Drug Manufacturers - General) 14 JPY

Out of every 100 JPY of revenue, 16 JPY is left as net profit.

Profitability in detail

Is it financially healthy?

Yes

Repaying all its debt would take 1.1 years of free cash flow. Its debt is larger than its cash.

Financial health in detail

Does it pay a dividend?

Moderate, safe
Yield
3.03%
Paid out of profit
39%
Raised in a row
3 years

You receive $0.50 per share a year. The company covers the payout with ease.

Dividends in detail

What do analysts expect?

No coverage

No analyst covers this stock.

Analysts in detail

What does it earn on?

By product

The company reports no revenue by product.

By region

The company reports no revenue by region.

Segments in detail

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.